A phase III trial to evaluate different chemotherapies in younger patients with Chronic Lymphocytic Leukemia

Cancer - Leukemia, Cancer
Syed Ali, MD

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA

Baystate Franklin Medical Center
164 High Street
Greenfield, MA

The purpose of this study is to compare the effects, good and/or bad, of two different therapies that include combinations of the drugs rituximab, fludarabine, cyclophosphamide and Ibrutinib
Diagnosis of Chronic Lymphocytic Leukemia not previously treated
Katie Colbeck